Dear friends and colleagues,
We are proud to organize the event under the auspices RSE-Radiology Society of the Emirates, JFIM, SIFEM, ECPO, Saint-Paul Breast Course, ASTARTE and AROME.
BCU 2023 has been awarded 15 ECMEC credits (European Continuous Medical Education Credits) by EACCME®. These points are convertible into an equivalent number of AMA PRA Category 1 Credits, the American Medical Association. This is a new step for the educational programs we are seeking to implement.
This year, we are addressing the topic of innovations in metastatic situations. The program is built on the model of a multidisciplinary professional consultation meeting MCM/RCP. Teaching and transmission of oncological knowledge must be done according to this transversal approach modeled on new multidisciplinary practices. It's the DNA of the BCU. It is essential to unite the different specialties to treat breast cancers that present many entity profiles requiring distinct and personalized management.
We hope you will join us in Dubai, in person or online.
Luc Rotenberg, MD, BCU General Secretary
A QR CODE will be present in the page. This will allow you to ask questions live to the moderators using your cell phone. A link will also be available if you are on your computer.
The sessions are in English.
The REPLAY of the sessions will start on the first day
The videos will be indexed with navigation features for computers (Microsoft, IOS, Android) tablets and mobiles (except iphone and ipad / videos and slides available without navigation).
The REPLAY zone will remain open for 2 months after the congress.
If you want to change your settings / password. Switch to a computer or a tablet and access the settings tab at the top right of the screen.
This area will be open to JFIM subscribers who are not registered to the congress
Delegates present in Dubai have online access and will be able to ask their questions via their smartphone.
• Short speeches
• A program and discussions based on multidisciplinary team meetings model
• LIVE SESSION on the JFIM websites with same-day replays
• Communication language will be English.
In 2021, 2.3 million women were diagnosed with breast cancer and over the last 5 years, 7.8 million women have been diagnosed with this disease, making it the most common cancer in the world. Over the past 40 years, advances in treatment have doubled patient survival and it is estimated that today 85% of women survive 5 years or more after a breast cancer diagnosis. Progress continues and solutions are emerging even in particularly difficult cases such as triple negative breast cancer with antibody drugs conjugates and chemotherapy.
Together, let's continue to move forward.
Have a good conference.